Revolution Medicines, Inc. is 21.5x more valuable than Immunocore Holdings plc by market capitalization ($30.65 B vs $1.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMCR | RVMD |
|---|---|---|
| Market cap | $1.43 B | $30.65 B |
| US-listed rank | #2369 | #454 |
| Revenue (latest FY) | $400.02M | $0.00 |
| Net income (latest FY) | -$35.51M | -$1.13B |
| Net margin | -8.9% | - |
| SEC filings | 265 | 782 |
Revolution Medicines, Inc. is 21.5x more valuable than Immunocore Holdings plc by market capitalization ($30.65 B vs $1.43 B).
In their latest fiscal years, Immunocore Holdings plc reported $400.02M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Immunocore Holdings plc and Revolution Medicines, Inc., or browse the full rankings.